If you live with bipolar disorder and you’ve asked a ketamine clinic in New York City whether they can treat your depression, you may have met one of two responses: a polite decline, or a page of disclaimers that answered nothing. The uncertainty is real, and it deserves a real answer rather than a shrug.
Here is the short version. Ketamine for bipolar disorder is not off the table. It does call for careful screening, a mood stabilizer already in place, and structured check-ins between sessions. When those pieces are there, the manic-switch risk appears low and watchable. Below, we cover what the research shows, how a bipolar-safe protocol works, and the two questions people ask most: can ketamine trigger mania, and how does it interact with Lamictal (lamotrigine).
This is education, not medical advice. IV ketamine is used off-label for psychiatric conditions, and any treatment decision should be made with your prescribing psychiatrist.
Why is bipolar depression harder to treat than regular depression?
Bipolar depression is tricky because the treatments that help regular (unipolar) depression can actually make it worse. Standard antidepressants carry a risk of flipping a depressive episode into mania or hypomania, a reaction sometimes called the “switch.” That risk is why antidepressants are used cautiously, if at all, in bipolar disorder.
That leaves a real gap. People with bipolar disorder spend far more of their lives depressed than manic. In bipolar II, a 2025 World Psychiatry review found that depressive episodes outnumber hypomanic episodes by a ratio of 39 to 1. Depression carries most of the burden, yet it has the fewest safe, fast-acting options.
That is why a fast-acting medicine that works differently is worth paying attention to. Ketamine acts on the glutamate system and supports neuroplasticity, the brain’s ability to build new connections, rather than targeting serotonin the way SSRIs do. We explore that mechanism further in our piece on ketamine, nervous system flexibility, and emotional resilience. Because the pathway is different, researchers have asked whether ketamine carries the same switch risk. The early answer is encouraging.
What does the research actually show about ketamine for bipolar depression?
The most direct evidence comes from a 2024 Yale-led study in the Journal of Clinical Psychiatry (efficacy and safety data), one of the few real-world reports on ketamine and esketamine for bipolar depression. Forty-five people received IV ketamine or esketamine twice a week for up to four weeks, alongside their existing medications.
The results, reported by Yale School of Medicine:
- 39% achieved a clinical response, a meaningful drop in depression scores
- 13% reached remission
- All were already on mood-stabilizing medication; ketamine was an add-on, never a replacement
That last point matters most. In every study, ketamine for bipolar depression is used alongside a mood stabilizer, never alone. A separate multicenter study confirmed the pattern: esketamine nasal spray produced similar improvement in bipolar and unipolar treatment-resistant depression, with no significant difference in affective switches between groups.
The honest takeaway: ketamine may help with the depressive side of bipolar disorder, but it does not treat the disorder itself. It addresses one piece of a condition that still needs ongoing mood-stabilizer care. For a broader look at IV ketamine in treatment-resistant cases, see Nushama’s ketamine infusion success rate for TRD in Manhattan.
Can ketamine cause mania?
Based on the research so far, the risk appears low and predictable, which means a care team can watch for it. In the Yale study, no one experienced mania or hypomania during the acute phase, when infusions were given twice a week.
Over longer follow-up the picture stayed manageable. Across 518 patient-months, there were 16 manic or hypomanic events. Only one required hospitalization. The median time to a manic or hypomanic event was 266 days, well beyond the median 95 days of treatment, leading the researchers to conclude that ketamine did not greatly raise the risk.
The risk is not zero, but it is low, tends to appear later rather than during early sessions, and shows up in ways a monitoring plan can catch. That is something you screen for and track, not an unpredictable danger.
Does ketamine interact with lithium or Lamictal (lamotrigine)?
Ketamine is continued alongside mood stabilizers like lithium and Lamictal, not substituted for them. Those medications act as a safety net against mania, and in every study, members stayed on them throughout treatment.
A few points to raise with your psychiatrist:
- Lamictal (lamotrigine) is originally a seizure medication that is now FDA-approved for maintenance treatment of bipolar I disorder, where it helps prevent mood episodes, especially depressive ones. It stabilizes mood without carrying a high risk of triggering mania. A 2022 systematic review found that lamotrigine may reduce some of ketamine’s dissociative side effects in healthy volunteers, though results in mood disorder patients were not conclusive. In practice, the two are used together under supervision, not swapped.
- Lithium still requires its usual monitoring: blood levels, hydration, and kidney and thyroid checks. Ketamine does not change that.
- Any medication change should be coordinated with your prescriber, not made independently around an infusion.
The guiding principle is coordination. Your ketamine provider and your psychiatrist should be talking to each other, and at Nushama’s Manhattan clinic, that communication is built into the intake process.
What does a bipolar-safe ketamine protocol look like?
A responsible protocol treats screening and monitoring as the core of care, not fine print you sign past. Our guide on what to expect during a ketamine infusion covers the general process. Here is what the bipolar-specific version adds.
History review before anything begins. A clinician reviews your mood history, medications, and recent episodes. A recent manic or hypomanic episode is a reason to stabilize first. Not a permanent no, but a “not yet.”
Confirmed mood-stabilizer coverage. Treatment proceeds when you have adequate coverage in place, such as lithium or lamotrigine. If that foundation is not set, addressing it comes first.
Structured mood monitoring between sessions. Rather than waiting for a problem, a good protocol tracks mood with validated scales between visits so early signs of activation are caught quickly.
Defined stop rules. Everyone knows in advance what would pause treatment: emerging hypomanic symptoms, sleep disruption, or rising activation, and what happens next.
Psychiatrist coordination. Your prescribing psychiatrist stays in the loop so mood-stabilizer dosing and ketamine care move together.
This is the difference between “we don’t treat bipolar” and “we treat bipolar carefully.” At Nushama in Midtown Manhattan, the careful approach is the standard.
A member’s story: bipolar II, PTSD, and suicidal depression
Research describes populations. Recovery happens one person at a time. Brittany’s case study on our blog describes someone living with bipolar II, PTSD, and severe suicidal depression who found sustained relief through a supervised IV ketamine protocol.
Ketamine did not erase her diagnosis or end the need for ongoing care. What it shifted was the depressive weight and the suicidal pull, the part of the illness that had felt immovable. Mood-stabilizer treatment and integration support remained essential. For readers whose trauma history sits alongside a mood disorder, our overview of ketamine for PTSD and trauma covers that side in more depth.
This is not a promise. For some people who had run out of options, careful ketamine care opened a door where there hadn’t been one.
How Nushama approaches ketamine for bipolar depression in Manhattan
At Nushama, ketamine care for bipolar depression starts with screening and stays anchored to it. Our physician-led team at 515 Madison Avenue, 21st floor, in Midtown Manhattan uses IV ketamine infusions dosed and supervised by an anesthesiologist. The clinic is steps from the E/M subway at 53rd Street and a short walk from the 6 train at 51st Street, with Grand Central about 15 minutes on foot.
Every journey includes preparation and integration sessions: the conversations before and after that help turn an experience into lasting change. The 18 private rooms are built around nature, art, and zero-gravity seating to support the mindset that deep work requires. For bipolar disorder, that means confirming mood-stabilizer coverage, coordinating with your psychiatrist, and monitoring mood between sessions. If you’re weighing delivery methods, our comparison of IV versus intramuscular ketamine explains why we favor IV.
If this feels relevant, bring this article to your psychiatrist. Talk through whether ketamine alongside your current treatment makes sense, then book a consultation at Nushama’s Midtown Manhattan clinic or call (646) 394-9996. Screened, supervised, and coordinated with your existing care: that is how this conversation should start.
FAQs
Can ketamine cause mania in people with bipolar disorder?
The risk appears low when ketamine is used alongside a mood stabilizer. In the 2024 Yale study, no one experienced mania or hypomania during the twice-weekly acute phase. Over longer follow-up, the events that did occur tended to appear months later, a pattern that structured mood monitoring is designed to catch. The risk is not zero, which is why screening and between-session check-ins matter. If your bipolar disorder also involves significant anxiety, discuss that overlap with your care team.
Can I take ketamine while I’m on Lamictal (lamotrigine) or lithium?
Yes, in the research, patients continued taking Lamictal, lithium, and other mood stabilizers during ketamine treatment. These medications serve as a guard against mania, which is why they are kept in place rather than stopped. Any change to your medication should be coordinated with your prescribing psychiatrist, not made on your own.
Is ketamine a cure for bipolar disorder?
No. Ketamine may help reduce the depressive symptoms of bipolar disorder, but it does not treat the underlying condition or replace mood-stabilizer care. Research consistently studies it as an add-on to existing treatment. Feeling better during a depressive episode does not eliminate the mood instability that defines bipolar disorder.
Why is IV ketamine used off-label for bipolar depression?
The FDA has approved esketamine (Spravato) only for treatment-resistant depression and for depressive symptoms in major depressive disorder with suicidal ideation, not for bipolar disorder. Any use of IV ketamine or esketamine for bipolar depression is therefore off-label, which is one reason careful screening and physician oversight matter so much.
What would make a clinic delay ketamine treatment for someone with bipolar disorder?
A recent manic or hypomanic episode, not enough mood-stabilizer coverage, or an unstable current mood are all common reasons to pause and stabilize first. Deferral is not a permanent no. It is a step to make sure the right foundation is in place before adding a fast-acting treatment.
Where is Nushama’s Manhattan ketamine clinic located?
Nushama’s flagship location is at 515 Madison Avenue, 21st floor, New York, NY 10022, in Midtown Manhattan near 53rd Street. The clinic is accessible via the E/M subway at 53rd Street, the 6 train at 51st Street, and Metro-North at Grand Central Terminal. You can reach the care team at (646) 394-9996 or request a consultation online.
Medically reviewed by Nushama’s clinical team at 515 Madison Avenue, New York, NY 10022. IV ketamine is used off-label for psychiatric indications and requires medical screening. It is not a cure for bipolar disorder and is used alongside, not in place of, mood-stabilizing treatment.
